C066-1275 Screening compound: 2-{6-[(4-methylpiperidin-1-yl)sulfonyl]-4-oxo-3,4-dihydroquinazolin-3-yl}-N-[2-(trifluoromethyl)phenyl]acetamide

C066-1275 Screening compound: 2-{6-[(4-methylpiperidin-1-yl)sulfonyl]-4-oxo-3,4-dihydroquinazolin-3-yl}-N-[2-(trifluoromethyl)phenyl]acetamide
C066-1275 Screening compound: 2-{6-[(4-methylpiperidin-1-yl)sulfonyl]-4-oxo-3,4-dihydroquinazolin-3-yl}-N-[2-(trifluoromethyl)phenyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C066-1275
2-{6-[(4-methylpiperidin-1-yl)sulfonyl]-4-oxo-3,4-dihydroquinazolin-3-yl}-N-[2-(trifluoromethyl)phenyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C066-1275

Molecular Formula

C23H23F3N4O4S (C23 H23 F3 N4 O4 S)

Compound Name

2-{6-[(4-methylpiperidin-1-yl)sulfonyl]-4-oxo-3,4-dihydroquinazolin-3-yl}-N-[2-(trifluoromethyl)phenyl]acetamide

IUPAC name

n/a

SMILES

CC(CC1)CCN1S(c(cc1)cc2c1N=CN(CC(Nc1c(C(F)(F)F)cccc1)=O)C2=O)(=O)=O

InChI

InChI=1S/C23H23F3N4O4S/c1-15-8-10-30(11-9-15)35(33,34)16-6-7-19-17(12-16)22(32)29(14-27-19)13-21(31)28-20-5-3-2-4-18(20)23(24,25)26/h2-7,12,14-15H,8-11,13H2,1H3,(H,28,31)

InChI Key

MGFGOJAFZQOFJE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14714790

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

508.52

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.269

Distribution Coefficient, logD

3.269

Water Solubility, LogSw

-3.87

Polar Surface Area

80.501

Acid Dissociation Constant (pKa)

12.70

Base Dissociation Constant (pKb)

-0.60

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.78

C066-1275 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Antiviral Annotated Library (21441 compounds)

CNS targets activity set (6557 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C066-1275 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C066-1275?
Check Price and Availability of C066-1275, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C066-1275 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C066-1275
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C066-1275
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C066-1275 available by request